# Use of a New Phototherapy Device (BBloo®) for the Treatment of Hyperbilirubinemia in the Newborn Infant

> **NCT02156050** · PHASE4 · UNKNOWN · sponsor: **Association Pédiatrique des Groupes d'Acuueil et de Recherche** · enrollment: 80 (estimated)

## Conditions studied

- Neonatal Hyperbilirubinemia

## Interventions

- **DEVICE:** two sessions of 4 hours Phototherapy treatment

## Key facts

- **NCT ID:** NCT02156050
- **Lead sponsor:** Association Pédiatrique des Groupes d'Acuueil et de Recherche
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2014-06-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02156050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02156050, "Use of a New Phototherapy Device (BBloo®) for the Treatment of Hyperbilirubinemia in the Newborn Infant". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02156050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*